FDA Approves PET Imaging Compound to Aid Early Diagnosis and Disease Monitoring

The Feinstein Institutes for Medical Research announced that the U.S. Food and Drug Administration (FDA) has approved an imaging compound its researchers developed as a diagnostic tool for people with suspected parkinsonian syndromes, including Parkinson’s disease. Fluorodopa F18 (FDOPA) is an injectable compound used during a PET…

Neuroscientist Awarded $2.9M NIH Grant to Study and Possibly Prevent Side Effects of Levodopa

The National Institutes of Health has awarded a $2.9 million grant to a Feinstein Institutes for Medical Research scientist working to better understand and prevent dyskinesia, a common side effect of the levodopa used to manage motor symptoms of Parkinson’s disease. The five-year award went to David Eidelberg,…